A Retrospective Analysis of the Incidence, Outcome and Factors Associated with the Occurrence of Euglycemic Ketoacidosis in Diabetic Patients on Sodium Glucose Co-Transporter – 2 Inhibitors Undergoing Cardiac Surgery

INTRODUCTION: SGLT2i is a new class of drugs used for type 2 diabetes. SGLT2i are known to cause EuKA in the perioperative period. Euglycemic ketoacidosis (EuKA) can cause life-threatening metabolic acidosis in the perioperative setting. Though the event rate of SGLT2i associated diabetic ketoacidos...

Descripción completa

Detalles Bibliográficos
Autores principales: Murugesan, Karthik Babu, Balakrishnan, Soundravalli, Arul, Anandhi, Ramalingam, Srinivasan, Srinivasan, Muralidharan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732953/
https://www.ncbi.nlm.nih.gov/pubmed/36254911
http://dx.doi.org/10.4103/aca.aca_47_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732953/
https://www.ncbi.nlm.nih.gov/pubmed/36254911
http://dx.doi.org/10.4103/aca.aca_47_21

Ejemplares similares